Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > busy times here...

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Feb 07, 2021 6:01pm

148 Views

Post# 32497050

RE:RE:RE:RE:RE:RE:RE:RE:busy times here...

No benefit? One company vs 4 and no need for sending patient cells all over Europe. So it's fine for them to collab with the European companies but not sigilion. Interesting logic.

Redbaron2211 wrote:

Bio I think the difference is I believe Sernova doesn't need Sigilon as we already have a very promising collaboration with the HemAcure consortium. maybe your right in that it would be better to work with one company and I can agree Sigilon could be a possibility but at this point I don't really see the benefit.

This;

The Device Conundrum
“We thought the cells would be the hard part and focused our efforts there. It’s obvious now having a functional device will be the limiting factor and there are few current options.”
Big Pharma executive at 2020 JPM

Sernova is in a very good position to negotiate.

RIP Sonny nice to put a face to the name.